Skip to main content
. Author manuscript; available in PMC: 2016 May 15.
Published in final edited form as: AIDS. 2015 May 15;29(8):867–876. doi: 10.1097/QAD.0000000000000629

Fig. 1.

Fig. 1

HIV-1 viral load and CD4+ T cell counts for participants A and B (top and bottom panels, respectively). Both participants experienced slow disease progression with persistent, but low-level viremia for 3–4 years prior to rising viral loads (virologic escape) and declining CD4+ T cell counts. Participant B initiated ART in January of 2012.